Free Account Opening + AMC Free Demat
Loading...

Concord Biotech IPO vs Yatharth Hospital IPO

Comparision between Concord Biotech IPO and Yatharth Hospital IPO.

IPO Details

Concord Biotech IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Yatharth Hospital IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Concord Biotech IPO is up to ₹1,551.00 Cr whereas the issue size of the Yatharth Hospital IPO is up to ₹686.55 Cr. The final issue price of Concord Biotech IPO is ₹741.00 per share and of Yatharth Hospital IPO is ₹300.00 per share.

  Concord Biotech IPO Yatharth Hospital IPO
Face Value ₹1 per share ₹10 per share
Issue Price (Lower) ₹705.00 per share ₹285.00 per share
Issue Price (Upper) ₹741.00 per share ₹300.00 per share
Issue Price (Final) ₹741.00 per share ₹300.00 per share
Discount (Retail)
Discount (Employee) ₹70.00 per share
Market Lot Size 20 shares 50 shares
Fresh Issue Size 1,63,33,333 shares
Fresh Issue Size (Amount) up to ₹490.00 Cr
OFS Issue Size 2,09,25,652 shares 65,51,690 shares
OFS Issue Size (Amount) up to ₹1,551.00 Cr up to ₹196.55 Cr
Issue Size Total 2,09,25,652 shares 2,28,85,023 shares
Issue Size Total (Amount) up to ₹1,551.00 Cr up to ₹686.55 Cr

IPO Timetable

Concord Biotech IPO opens on Aug 04, 2023, while Yatharth Hospital IPO opens on Jul 26, 2023. The closing date of Concord Biotech IPO and Yatharth Hospital IPO is Aug 08, 2023, and Jul 28, 2023, respectively.

  Concord Biotech IPO Yatharth Hospital IPO
Anchor Bid Date Aug 03, 2023 Jul 25, 2023
Issue Open Aug 04, 2023 Jul 26, 2023
Issue Close Aug 08, 2023 Jul 28, 2023
Basis Of Allotment (Tentative) Aug 11, 2023 Aug 02, 2023
Initiation of Refunds (Tentative) Aug 14, 2023 Aug 03, 2023
Credit of Share (Tentative) Aug 17, 2023 Aug 04, 2023
Listing date (Tentative) Aug 18, 2023 Aug 07, 2023
Anchor Lockin End date 1 Sep 10, 2023 Sep 01, 2023
Anchor Lockin End date 2 Nov 09, 2023 Oct 31, 2023

Financials

Concord Biotech IPO P/E ratio is 32.29, as compared to Yatharth Hospital IPO P/E ratio of 39.16.

  Concord Biotech IPO Yatharth Hospital IPO
Financial
Concord Biotech IPO Financial Information (Restated Consolidated)
Period Ended31 Mar 202131 Mar 202231 Mar 2023
Assets1,182.551,312.801,513.98
Revenue630.75736.35888.48
Profit After Tax234.89174.93240.08
Net Worth999.371,103.221,290.00
Reserves and Surplus
Total Borrowing86.3560.5931.24
Amount in ₹ Crore
Yatharth Hospital IPO Financial Information (Restated Consolidated)
Period Ended31 Mar 201931 Mar 202031 Mar 202131 Mar 202231 Mar 2023
Assets256.56287.20308.77426.02485.97
Revenue102.07146.18229.19402.59523.10
Profit After Tax3.98-2.0519.5944.1665.77
Net Worth55.6054.2972.46116.89182.96
Reserves and Surplus
Total Borrowing164.57184.57186.11258.19263.78
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue) 44.08% 91.34%
Promoter Shareholding (Post-Issue) 44.08% 66.32%
P/E Ratio 32.29 39.16
Market Cap ₹7752.06 Cr. ₹2575.51 Cr.
ROE 20.06%% 35.95%%
ROCE 24.27%% 26.10%%
Debt/Equity 1.44
EPS ₹20.79 ₹10.09
RoNW 20%% 35.95%%

Shares Offered

In the Concord Biotech IPO retail investors (RII) are offered 73,20,479 shares while in Yatharth Hospital IPO retail investors are offered 73,20,479 shares. Qualified institutional buyers (QIB) are offered 41,83,130 shares in Concord Biotech IPO and 45,77,004 shares in Yatharth Hospital IPO.

  Concord Biotech IPO Yatharth Hospital IPO
Anchor Investor Reserveration 62,74,695 shares 68,65,506 shares
Market Maker Reserveration
QIB 41,83,130 shares 45,77,004 shares
NII 31,37,348 shares 34,32,754 shares
RII 73,20,479 shares 80,09,759 shares
Employee 10,000 shares 0 shares
Others
Total 1,46,50,957 shares 1,60,19,517 shares

Bids Received (Subscription)

Concord Biotech IPO subscribed 24.87x in total, whereas Yatharth Hospital IPO subscribed 37.28x.

  Concord Biotech IPO Yatharth Hospital IPO
QIB (times) 67.67x 86.37x
NII (times) 16.99x 38.62x
Big NII (times) 19.30x 41.76x
Small NII (times) 12.37x 32.34x
RII (times) 3.78x 8.66x
Employee (times) 24.48x
Other (times)
Total (times) 24.87x 37.28x

Comments

Add a public comment...